Skip to main content
OpenTrials

Clinical trial condition

Metastatic Melanoma

Explore clinical trials studying Metastatic Melanoma. Study availability and eligibility vary by location and protocol.

231 public trials 37 recruiting studies
Refine in advanced search Browse all conditions

Metastatic Melanoma trial results

Not yet recruiting

A Study to Assess the Safety, and Tolerability of Nivolumab + Relatlimab Fixed-Dose Combination (FDC) In Unresectable or Metastatic Melanoma Participants In India

NCT07459543

Conditions
Melanoma, Metastatic Melanoma, Neoplasms, +11 more
Locations
  • Local Institution - 0009 Navi Mumbai, Maharashtra, India
  • Local Institution - 0008 Pune, Maharashtra, India
  • Local Institution - 0003 Bhubaneswar, Odisha, India
  • Local Institution - 0002 Chennai, India
View Trial Details
Active, not recruiting

Ipilimumab With or Without Sargramostim in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery

NCT01134614

Conditions
Advanced Melanoma, Melanoma, Metastatic Melanoma, +18 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Stanford Cancer Institute Palo Alto Palo Alto, California, United States
  • VA Palo Alto Health Care System Palo Alto, California, United States
  • Eisenhower Medical Center Rancho Mirage, California, United States
View all 257 locations
View Trial Details
Active, not recruiting

Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain

NCT06500455

Conditions
Adenocarcinoma, Anatomic Stage IV Breast Cancer AJCC v8, Brain Diseases, +52 more
Locations
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
  • University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
  • Mercy Hospital Fort Smith Fort Smith, Arkansas, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
View all 270 locations
View Trial Details
Active, not recruiting

Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC

NCT04140526

Conditions
Adenocarcinoma, Adenoid Cystic Carcinoma, Adnexal Diseases, +94 more
Locations
  • Highlands Oncology Group Springdale, Arkansas, United States
  • University of California at Davis Davis, California, United States
  • The Oncology Institute of Hope and Innovation Downey, California, United States
  • City of Hope Cancer Center Duarte, California, United States
View all 37 locations
View Trial Details

Related conditions